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Abstract
The presence of cognitive deficits in schizophrenia is a fact widely confirmed by a more 
than abundant literature. The existence of these deficits cannot be ignored, given their 
presence even with stabilized symptoms and their proven correlation with the function-
ing of the subject. The following chapter focuses on describing the main affected cog-
nitive domains most frequently described in this pathology, mutually before and after 
the appearance of the clinical signs, as well as reviewing the presence of these affected 
domains in first-degree relatives of these patients. The existence of these deficits in rela-
tives reveals that these alterations can not only be considered as markers of heritability 
and risk for the development of the pathology, but that their ignorance, in the family 
context, is also related to an important stain in the perception of the quotidian aspects, 
in the healthy interaction between relatives and an impact on the overall functionality of 
the subject.
Keywords: cognitive impairment, schizophrenia, cognitive endophenotype, family, 
psychosis
1. Introduction: cognitive impairment in schizophrenic disorder
There is considerable evidence of the presence of cognitive deficits in schizophrenic disorder 
that are unfavorably correlated to the daily functioning of these patients [1]. These dysfunc-
tions are present before the beginning of the psychotic symptomatology [2]. Cognitive déficits 
in schizophrenia affect most of cognitive functions and are especially relevant in: memory and 
learning; abstraction and executive functions; processing speed and attention [3–7].
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
It is important to point out that there are similar cognitive impairments, in much lower inten-
sity, in close relatives, and these deficits can be considered as potential cognitive endopheno-
type markers of the disorder [8–13]. From this data, it can be accepted that, in many cases, the 
effect of these alterations, potentially, may be affecting the functioning of any family nucleus 
and not only the patient or relative at risk of developing disease.
These data show the existence of a biological basis, despite the undeniable influence of 
environmental factors on the development and course of both pathologies. In this sense, the 
DSMIV-TR [14] notes that: “Although numerous data suggest the importance of genetic factors in 
the etiology of schizophrenia, the existence of a substantial discrepancy in the frequency of monozygotic 
twins also indicates the importance of environmental factors”.
As expected, this cognitive dysfunction has influence in the main aspects of daily life [15]. 
Respecting the family point of view, there is also a great ignorance of the existence and influ-
ence of these cognitive symptoms present in the affected relatives. In general, it is suggested 
that the psychoeducational programs made for this subject directed to family members pro-
vide them with an important first step. These programs provides means in order to under-
stand these factors, which make an important stain in their overall functioning, and therefore, 
in the daily life of these patients [16–19]. On the other hand, it is important to point out that 
the same patients do not usually present insight of their deficits, and when they do, although 
they are usually associated with higher levels of adherence to treatment, they also tend to 
do so with a loss of self-confidence [20]. This fact indicates that family interventions in the 
education of cognitive aspects should not only stay there and should also involve a research 
for solutions of family support in other ways. At this point, it cannot be ignored the effect on 
the family dynamics of the probable presence (even being slight) of these deficits in any of the 
relatives of the affected subjects. Their awareness and identification are important in order to 
carry out a family intervention.
2. Cognitive deficit in schizophrenia
One of the main recently advances of the concept of schizophrenia has been the confirmation 
that this disorder is primarily associated to cognitive deficits, do not being a consequence 
to symptoms or drugs [21]. Nevertheless, the idea that cognitive domains played a funda-
mental role in this disorder was not so recent. Since the first descriptions of schizophrenia, 
which was known under the Dementia praecox label, the aspects related to what it is now 
understood as cognitive deficit were considered as central symptoms of the picture. Besides 
the essential idea of Bleuler was that the core of schizophrenia, its fundamental symptoms, 
was the fragmentation of the thought process and delusions and hallucinations were acces-
sory symptoms, a consequence of the main process [22, 23]. It has also been shown that this 
cognitive deficit has not only been described in long-standing schizophrenic patients [24], but 
is also present in patients with a first psychotic episode [25–27], in remission [28], in patients 
without antipsychotic medication [21, 29] and even in studies in high-risk subjects [30] and in 
close relatives and healthy patients with schizophrenia [12].
It is estimated that among 61–78% of patients with schizophrenia manifest a significant 
level of cognitive deficit [1] reaching between 1 and 2 standard deviations below the control 
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groups of the same age [6, 31]. These cognitive deficits seem independent of positive symp-
toms [32] and are maintained throughout the course of the disease.
Although some early investigations [33] showed that about 27% of schizophrenic patients, 
after neuropsychological evaluation, could not be considered deficit, in fact, it has been 
proven that they would continue to present neuropsychological deficit compared to healthy 
subjects, even matching IQ measurements [34]. This group of patients, without supposed 
deterioration, would show high levels of premorbid functioning, but once the disease was 
diagnosed, this would be considerably lower [35]. In addition, discordant monozygotic twin 
comparisons for schizophrenia suggest that almost all affected twins perform worse on cogni-
tive tests than their unaffected twin [36]. In this sense, it can be safely talked about cognitive 
deficits in schizophrenic patients although, in any case, it is very likely that their cognitive 
performance is below than what was expected in the absence of disease. It is also interesting 
to mention that several authors have found a worse performance in tasks of work memory 
(especially in visual) and in learning verbal tests and free memories in unaffected monozy-
gotic twin brothers and, even a lesser degree, in not affected dizygotic twin brothers against 
controls [37–40].
It is interesting to point out that many patients have a lack of awareness of cognitive dys-
function. Those who are better aware of their deficits are not associated with a lower use 
of treatment, nor with a lesser deterioration of executive function. But they do have better 
results in the rehabilitation of some cognitive domains, in adherence to treatment and in their 
functional capacity [41, 42].
The neurocognitive dysfunction affects the ability to perform activities of daily living, impairs 
the ability to solve social problems [15, 16] and has proved to be the better predictor of rein-
corporation to activities in social and community settings [43, 44] and, especially, in terms 
of work rehabilitation and maintenance works [45–48]. These data review the importance 
of cognitive domains as a reliable scale of clinical improvement [15, 49–52] and, as is to be 
expected, the degree of cognitive impairment implies a worse adjustment in the quality of life 
of these patients [52–54]. Some authors also consider cognitive functions as an integral part 
of the concept of resistance to treatment [55]. On the other hand, several studies emphasize 
the importance and efficacy of cognitive rehabilitation treatments in early stages of psychosis 
[56, 57].
As expected with these data, the cognitive alteration in schizophrenia is the current focus of 
attention for the research of therapeutic strategies, both pharmacological and psychological. 
Regarding the interventions on cognitive domains, the pharmacological treatment, although 
it has offered certain results, has not been very encouraging [58], however studies using cog-
nitive stimulation (training in executive skills, memory and other cognitive processes) have 
achieved more hopeful data [59–62].
2.1. Cognitive domains affected
Patients with schizophrenia have, comparing with healthy subjects, problems in perform-
ing almost all conventional neuropsychological tests. The most widely affected functions 
are executive tasks. Memory and attention, in their different modalities, are not the only 
ones affected, but it is these domains that stand out especially about a generalized cognitive 
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dysfunction. The functions relatively preserved in schizophrenia are usually verbal knowl-
edge and linguistic comprehension and naming. Cognitive functioning in schizophrenia is 
considered a primary or essential characteristic of the disorder [15, 63], so that schizophrenia 
is now considered to be a complex disorder whose base is fundamentally neurocognitive 
[64, 65]. For a review of the characteristics of these disturbances see Table 1.
2.2. Description of the disturbance in the affected domains
In general, it can concluded that the meta-analysis by Schaefer et al [69] would indicate that 
patients with schizophrenia would present important alterations in: Attention, especially in 
sustained attention and interference control; significant deficits in the operational memory 
(maintenance of information and manipulation) and important alterations in long-term mem-
ory. However, the implicit memory, specifically the so-called procedural memory, related to 
the ability to learn psychomotor skills, would be relatively preserved [73] and the recogni-
tion of verbal material was not as altered as the delayed memory. They presented important 
alterations in the different components of the executive functions such as cognitive flexibility 
and planning and serious alterations in the speed of processing.
Going in dept. the studies of executive functions in schizophrenic patients, these tend to 
describe a greater presence of persistent responses. The Wisconsin card sorting test [74] indi-
cates that these patients tend to have a low number of categories achieved and many persis-
tent responses, which can be seen as a deficit of cognitive flexibility [75]. This inability to select 
the relevant information and reject the irrelevant has also been documented using tasks such 
as the Stroop test [76–78] or the Tower of Hanoi [79].
This inability to inhibit response (which would affect to planning and organizing actions, 
persist in an activity and find novel solutions) is present, to a greater or lesser degree, in these 
patients, even in the case of not showing up serious dysfunctions in attention capacity and 
operative memory (necessary for an adequate executive functioning) [52, 70].
Regarding to memory in schizophrenia, it is common to see studies showing general altera-
tions in all memory processes. It shows that there is poor performance in declarative (explicit) 
memory, short-term and long-term memory, intentional learning, operational memory, 
semantic memory and priming. However, non-declarative memory (implicit) seems be less 
affected and procedural memory seems to be preserved [80, 81].
Some authors have considered that the alteration of autobiographical memory [82] as well 
as in prospective memory (the ability to remember the performance of planned actions in 
the future) [83] and the memory of the source (of the contextual aspects of the information: 
Where, when, etc.) [84] are the product of a general deficit, especially related to a reduced 
executive function [70].
The studies of working memory in schizophrenia reflect the existence of deficits in the capacity of 
storage/apprehension [85], although it is considered if such storage difficulties could be linked 
to alterations in the process of coding the information (more related to the executive function), 
Psychosis - Biopsychosocial and Relational Perspectives46
Balanzá-Martínez and Tabarés-Seisdedos [66] highlight the following aspects:
• They affect significantly the majority of patients.
• On a generalized cognitive impairment, the most intense deficits are linked to memory, attention and executive 
functions.
• They are not secondary to psychotropic drugs, institutionalization or symptoms, although they may be related 
to negative symptoms.
• They are very stable during the evolution of the disorder.
• They are present since the first episode, even in the premorbid stages.
• They are also present in healthy patients relatives (cognitive endophenotypes) [67, 68].
• They are indicators of functional prognosis.
• Nowadays, they constitute a therapeutic objective.
The meta-analysis conducted by Shaefer et al. [69] concluded:
• There is evidence of a broad cognitive deterioration in schizophrenia, which can be considered moderate to 
severe compared to control subjects in all the neurocognitive measures studied.
• The cognitive deficits are somewhat greater in the domains of processing speed and episodic memory.
• Studies of diverse world regions in which a study of cognition is carried out present very few differences to each 
other.
• The studies showed higher percentages of involvement in male patients.
• The cognitive deterioration does not keep too much relation with the majority of the measures of symptom-
atology, something in contrast with the studies that highlight moderate but statistically reliable associations 
between cognition and negative or disorganized symptoms [32].
• Interestingly, they found no significant relationship between the duration of the disorder and cognitive decline.
Crespo, Rodriguez-Sanchez, Barbas-Calvo, Duarte-Armolea and González-Blanch [70] clarify that the existence 
of these deficits (to a much lesser degree) is not exclusive to patients and is often found within first-degree family 
members. Considering the affected domains and controlling medication variables, it can be considered:
• Attention: Difficulty to inhibit irrelevant information. Presence of these deficits in both patients and their 
children (higher than controls and young subjects at high risk for affective disorders).
• Executive functions: Difficulties in the use of problem solving strategies, self-control and supervision of own 
behavior. In first-degree patient’s relatives, there have been problems in verbal fluency, inhibition of an arrogant 
response pattern or tasks with a change in cognitive function.
• Working memory: Deficit in the storage capacity of information (verbal and spatial) and also emphasize the role 
of working memory as an essential element for the processing of information, which malfunction compromises 
the execution of other cognitive systems. It is interesting to complete it with the study of Guimon, Padani, Lutz, 
Eack, Thermenos and Keshavan [71] about how emotional distracters impacted more on their performance in 
working memory tasks than in control subjects. Also note that Botero et al. [72] tested performance on tasks 
involving verbal work memory and the results were lower in subjects with schizophrenia and their relatives that 
in the controls of the community.
• Memory: Deficits to remember are present, to a lesser degree, in healthy relatives of patients. These memory 
deficits are aggravated by attention problems, working memory and coding difficulties.
• Speed of processing: Indicate a slowdown that affects other cognitive domains.
• Psychomotor functioning: Significant psychomotor slowdown even in first episode patients and, to a lesser 
degree, in parents of patients.
Table 1. Presence of cognitive disturbance in schizophrenia and first grade relatives.
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rather than in processes related to the actual maintenance of the information. Authors such 
as Sharma and Antonova [86] and Brebion et al. [87] consider that schizophrenic patients did 
not use the properties/facilities of the material to be memorized in learning (for example, 
grouping it by categories or sequences) because they presented problems when are making 
complex coding strategies (based on the characteristics of the information). Although, these 
alterations in coding could be secondary related to the generalized slowdown in processing 
speed [88]. It is also point out that deficits in working memory could be due to errors in the 
search, maintenance and manipulation of information.
2.3. MATRICS study (measurement and treatment research to improve cognition in 
schizophrenia) of the National Institute of Mental Health (NIMH). The cognitive 
search in schizophrenia
One of the most important study projects of cognition in schizophrenia comes from the 
National Institute of Mental Health (NIMH) in the United States. The MATRICS initiative, 
Measurement and Treatment Research to Improve Cognition in Schizophrenia, is a program 
whose initial objective was to provide data that facilitated the development of drugs that 
improve the deficits presented in cognition in schizophrenia [89, 90] and that adopted as an 
initial objective the identification of the domains of cognitive effects in schizophrenia as well 
as the development of a battery for their evaluation.
The MATRICS project [91, 92] pointed out seven cognitive scopes in which patients with 
schizophrenia presented critical deficits: Speed of processing, attention/vigilance, working 
memory, learning and verbal memory, learning and visual memory, reasoning and problem 
a solving, and, a domain that was often ignored in many studies, social cognition.
2.4. Social cognition and schizophrenia
It is interesting to emphasize the relevance that social cognition has achieved in schizophre-
nia. This comes, among other sources, from the evidence that relates social cognition to social 
functioning [15, 93, 94] as well as for its mediating role between neurocognition and social 
functioning [95, 96].
Although there is no generalized consensus on the domains that make up social cognition, 
most authors identify five domains: Emotional processing, theory of mind, social perception, 
social knowledge and attribution style [97]. Even if the domains of emotional processing 
(perception and handling of emotions), and of theory of mind are usually cited as the most 
affected in schizophrenia, it can be accepted, based on the investigations carried out, that 
there is a mishandling of all of them on some of these patients [98].
Considering the meta-analyses of Chan et al. [99] and Savla et al. [100] it is indicated that 
people with schizophrenia present serious and generalized deficits in social cognition, espe-
cially in perception of emotions. More specifically, they show important difficulties in the 
perception of facial emotions as well as in the identification and discrimination of different 
emotions compared to undiagnosed controls. Difficulties in the processing of emotions were 
also observed in emotional prosody, that is, in the emotional tone of the voice. This alteration 
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is found in early stages of the disorder [101]. They also found that people with schizophre-
nia have major alterations in the theory of mind. In general, they also found alterations, 
although to a lesser extent to the previous ones, in social perception (ability to identify roles, 
social norms and social context as well as social knowledge that refers to the conscience of 
roles, norms and objectives that characterize social situations and direct interactions) [102]. 
However, Savla et al. [100] did not find significant differences in attribution biases between 
people with schizophrenia and non-diagnosed controls.
Regarding the presence of alterations in social cognition in relatives of patients, it is usu-
ally noted that patients score significantly worse in all domains of social cognition evaluated 
compared to controls and in the attribution style domain compared to family members [103].
In the Mondragón-Maya et al. review [104] point out that consistent discoveries on deficits 
in the theory of mind have been reported in family members of patients with schizophrenia 
compared to control subjects. In this sense, two meta-analyzes have reported effects (from 
modest to moderate) on alterations of the theory of the mind in unaffected relatives [105, 106].
Moreover, Mondragón-Maya et al. [104] consider that studies of the other fields of social cog-
nition in family members offer more scarce and inconsistent results, requiring further investi-
gation. Cella et al. [107] and the meta-analysis of Lavoie et al. [106] reported moderate déficits 
in social perception in relatives of schizophrenia versus controls. However, later, Lavoie et al. 
[108] did not find that parents of patients with schizophrenia showed worse performance than 
controls in social perception tasks. Regarding attribution style, Rodríguez et al. [103] reported 
that there were no deficits in the unaffected relatives of patients with schizophrenia. Studies 
on emotional processing in unaffected family members of patients with schizophrenia are 
also scarce. Despite this, some studies have reported worse performance of their relatives to 
identify emotions compared to controls [109]. The meta-analysis of Lavoie et al. [106] found a 
moderate deficit in emotional processing of unaffected family members, especially in tasks of 
emotional identification. However, this result is not completely generalize and needs further 
investigation, since it focuses on emotional identification skills, more than other components 
of emotional processing, such as emotional regulation [104].
2.5. Clinical status and cognition
It is important to emphasize that these deficits are not a direct consequence of pharmacologi-
cal treatment, nor of the institutionalization situation or other factors such as lack of motiva-
tion or distractibility due to psychotic symptoms [3]. Cognitive deficits in schizophrenia affect 
the majority of cognitive functions [6], but they are especially marked in executive functions 
and memory [3, 4]. This cognitive deficit is presented with autonomy of positive and negative 
symptoms, even when there is a greater association with this latter ones [63, 110].
The systematic review of Dominguez et al. [32] (58 studies, 5009 individuals) shows a relation 
between the psychopathological dimensions of psychosis (negative, positive, disorganized 
and depressive) and measures of neurocognitive impairment in subjects with non-bipolar 
psychosis. The results showed that negative and disorganized symptoms are significantly 
but modestly associated with cognitive deficits. The positive and depressive dimensions 
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were not associated with neurocognitive measures. The patterns of association between these 
dimensions were stable in all neurocognitive domains and were independent of age, sex and 
chronicity of the disease. In addition, significantly high correlations were found for the nega-
tive dimension in relation to verbal fluency and in the disorganized dimension for reasoning/
problem solving and attention.
2.6. Origin of cognitive deficit and family endophenotypes
Traditionally, two hypotheses about this disease have been considered [111]: The neurodevel-
opmental hypothesis, which considers that schizophrenia would come from an early disorder 
of brain development, which would be present in a relatively silent way during childhood, 
and that it would begin to exacerbate during adolescence and the beginning of adulthood 
with cerebral maturation [112, 113]. The neurodegenerative hypothesis indicates the existence 
of an active pathological process associated with periods of exacerbation, due to the neurotox-
icity of acute psychosis, which would explain the progressive deterioration observed in these 
patients in the first years of the disorder. The evidence points out that although there is an 
alteration in neurodevelopment in schizophrenia [2, 111, 114, 115], but neither can be ignored 
that there are progressive brain changes in the appearance of psychotic crises not always 
associated with treatment [111].
There is evidence which shows that these cognitive disorders are prior to the onset of psy-
chotic symptoms and the diagnosis of the disorder [114] and even seem to indicate that, the 
subjects who will suffer from schizophrenia, already in the 7–13 years of age, obtain lower 
scores in neurocognitive tests compared to subjects who did not develop it. These scores will 
remain relatively stable until descending significantly between 13 and 38 years [2]. These 
data would be in favor of the authors who suggest that these dysfunctions are significant and 
central to the disorder [116] and close to the neurodevelopmental hypothesis [112].
Similar cognitive alterations are also found, but to a lesser extent, in first-degree relatives of 
schizophrenia [8–10] and in people at risk for the disorder [8, 117]. This fact suggests that cogni-
tive alterations may represent the expression of genetic vulnerability to schizophrenia and may 
be endophenotype for psychosis [118]. Other studies have indicated functional dysfunctions 
in brain regions (medial prefrontal cortex, posterior cingulate cortex, and superior temporal 
gyrus) in both non-psychotic patients and first-degree relatives and healthy controls [119, 120].
The alteration of executive functions in schizophrenia has come to be proposed as a phe-
notypic marker of the disease. Not surprisingly, studies with first-degree relatives of these 
patients have shown that they share some of these executive deficits [70].
Also note that the heritability of schizophrenia is high and family studies indicate that first-
degree relatives of patients with schizophrenia have a seven times greater risk of developing 
the disease compared to individuals who do not have an affected family member [121].
2.7. Some considerations from interventions from the family
Antipsychotic drugs, although essential in the treatment of the disease, have a limited capac-
ity to improve the general cognitive functioning of patients with schizophrenia. Numerous 
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studies agree that including psychosocial treatments of psychoeducation, family intervention, 
skills training and cognitive interventions for long periods (a year or more), produce a greater 
functional improvement especially in patients of first psychotic episodes which can be only 
obtained with drugs [122–127].
As previously pointed out, in general the data suggest that many subjects affected by schizo-
phrenia are poor assessors of their own cognition [19, 128, 129] and its daily functioning. In 
this line, it is important to indicate that, in the study by Poletti et al. [19] noted that close rela-
tives of patients also have great difficulties in recognizing the presence of cognitive deficits 
in their affected relatives and they usually interpret them as a product of their personality, 
attitude, lack of interest or motivation, instead of understanding that they are due to the dis-
order. In addition, it should be remembered that the relatives of patients with schizophrenia 
also present more neuropsychological alterations than the control subjects [130], such deficits 
could represent an important difficulty to identify some symptoms of schizophrenia that can 
be present in the family.
It is also important to remember that knowing the biological and genetic origins of mental disor-
ders does not help reduce social distances or avoid stereotypes. (In fact, Angermeyer et al. [131] 
found the opposite. They describe they were related to an even stronger rejection). In family 
interventions of patients with schizophrenia, although the lack of knowledge the parents is linked 
to a poor vision of the patient on their deficits and on their awareness of disease, [132] these must 
go further. The study by Macgregor et al [133] concludes that it should not be focused only on 
giving information and observing compliance with treatment, but also on other parental factors 
such as better cognitive performance (since there is an association between cognitive performance 
of parents -especially in executive functioning and verbal comprehension - and the perception of 
the illness of their children [18]), daily contact, a lower attitude of rejection are associated with 
better patients awareness of their disorder. Therefore, they conclude, that these factors should 
be included in specific programs aimed at caregivers, including cognitive intervention aimed at 
improving the cognitive flexibility of parents. In general Macgregor et al. [17] support the intro-
duction of cognitive remediation techniques in family interventions. The objective would be to 
reduce the cognitive biases of healthy first-degree relatives. The perception of the patient and 
parents is an essential step on the road towards a good prognosis of the disorder.
It should be noted that, within family influences, not all are reduced to the simple knowl-
edge of the symptoms. At this point, one of the most accepted hypotheses is that high levels 
of expressed emotion (EE) in front of a sick family member can lead patients to feel more 
ashamed and less open to self-understanding about their disorder [133]. This hypothesis 
underlies the idea of the influence that the development of the parent–child relationship 
implies [134]. Commonly, family therapy is recommended to reduce stressful family interac-
tions and increase support, this, joined to cognitive training exercises are interventions that 
not only improve the well-being and functioning of patients, but also, even during the pro-
dromal phase [135], can promote resiliency to stress, which has the potential to prevent the 
appearance of psychotic episodes [136].
Other family aspects to consider are the ones pointing out by Raffard et al. [18] in their study: 
In the prodromal phase of psychosis, patients often show nonspecific symptoms, such as 
anxiety and depression, social deterioration, drug abuse or alcohol, which are not interpreted 
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as possible symptoms of a major condition [137] and are associated with behavior typical of 
adolescence [138]. If a young individual is labeled as “sick” or “psychotic” is always a source 
of anguish [139, 140] and a potential risk of stigma [141], which can lead to maladaptive cop-
ing such as denial, avoidance and difficulties [142, 143]. The presence of cognitive deficits in 
patient and parents, can lead both to the difficulty to receive corrective feedback from profes-
sionals and to affect the ability to adequately judge the psychotic experiences of their chil-
dren, which can lead parents to use coping strategies “avoidant” (as denial/disengagement) 
instead of more “approximation” strategies (such as seeking social support, reinterpretation, 
acceptance).
As already mentioned, there are programs of psychoeducation of cognitive symptoms for 
family members of schizophrenia and numerous intervention programs of cognitive symp-
toms in schizophrenia [59–62]. But nowadays, there are hardly any specific programs focused 
on cognitive intervention since the same family. Among the very few family intervention 
programs we can mention the Family-Directed Cognitive Adaptation (FCA). This program 
is designed to teach patients and family members the neurocognitive problems associated 
with schizophrenia; how to develop compensation strategies to minimize their impact on 
family and daily functioning; and teach families how to implement adaptive strategies to 
solve problems [144, 145].
In a first application of the program to a patient who lived with his mother [144], these 
authors, in addition to cognitive problems, also found a situation of abandonment of activ-
ities (friends, leisure), sedentary life, absence of social life beyond of family members, dull 
mood, poor diet, side effects of drugs and a family activity limited to doing small house-
hold chores (often incompletely, although the evaluations revealed a capacity to do tasks 
preserved, he used to leave them in the hands of his mother, including medication and 
calls to the doctor). In spite of everything, patient and family could take an active role in 
solving problems and generate practical objectives. They were taught what cognitive skills 
were and then strategies for adapting them in daily life (some of them already used list of 
“things to do“ to avoid frequent forgetting of the patient). Then the best and worst pre-
served domains were observed (the latter: verbal memory, processing speed and executive 
function) and a series of strategies were introduced to overcome these difficulties (such 
as: using notes and reminders, dividing goals into smaller steps and maintaining short 
and simple communication …). An identification and problem solving format was applied 
(similar to that used in behavioral family therapy programs [146]) to prioritize goals (take 
care of food, make calls, medication …) and specific strategies aimed at addressing these 
barriers (lists of foods, use of agendas, summarize what is heard and ask for clarification of 
what was not understood, exercise …) and cognitive-behavioral technique to see the evi-
dence for and against beliefs and concerns (this technique also it was used by the mother 
to test the irrational beliefs of the patient-possible residual symptoms-instead of acting 
against them fearfully or hostilely. Assertiveness and communication skills programs 
were also applied, identifying barriers and examining evidences (pros and cons). As the 
tasks increased, mutual trust improved, the patient was able to do more skills on his own 
and the burden of the mother decreased, improving the relationship and communication 
between them.
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In a second pilot application of the program to a larger sample [145], the aspects considered 
most useful by relatives were: “Learning about cognitive deficits related to schizophrenia” and 
“learning about the specific cognitive strengths and difficulties of my relative” and patients 
considered: “Learning about my strengths and cognitive difficulties“and “learning strategies 
to overcome cognitive difficulties“. This pilot study suggests that it may have helped family 
members to better understand the nature of cognitive challenges, which may have reduced 
feelings of irritation or guilt and with them the family burden. Despite the limitations of 
this study, it can be affirmed that it was shown that families could be involved in a program 
designed to teach strategies to reduce the effects of cognitive disabilities on daily living skills. 
They also suggested some benefits in terms of improved functioning and reduced family 
burden. Finally, they pointed to the natural and supportive role that relatives play in helping 
a member(s) with schizophrenia to have more control over their life and to progress towards 
important personal goals.
However, these achievements were not maintained. Although the program was effective dur-
ing its implementation, it is possible, according to its authors, that 16 sessions are insufficient 
for families to master the basic fundamentals to implement cognitive adaptations on their 
own (not in vain, it is usually recommended that cognitive training last more than 1 year); 
or that the families that would have benefited from the program were gradually reducing 
participation in reinforcement sessions and did not facilitate the maintenance of the results.
Within other compensatory deficit strategies programs that involve the family exits the 
9-months Cognitive Adaptation Training (CAT) [147]. It is especially applied, with the pur-
pose of recovering vocations (work, studies) in first episode patients. Although the results 
seem promising, they are still pending confirmation in studies of larger samples.
It can be concluded that, in addition to inquiring into the ways of application of specific pro-
grams to treat cognitive deficits from the family framework (there are few programs yet, and 
despite having apparent good results, are still pending on a further study), the simple fact of 
giving knowledge about the symptomatology of schizophrenia is not always enough for par-
ents to adopt attitudes of understanding towards the symptoms of their children. As pointed 
out by Friedman-Yakoobian et al. [145], rehabilitation and intervention should be oriented to 
improve the daily needs of each patient and it cannot be ignored the fact that many of these 
patients live with their families. Even when they live far away, relatives usually get involved 
in trying to give support (financial, emotional, etc. …) and a common consequence of this is 
that family members often suffer significant levels of stress, anxiety and caregiver burden. 
Therefore, we must also address attitudes such as the acceptance and overcoming of defeatist 
and critical attitudes, which help to avoid the denial of symptoms and improve their percep-
tion of the disorder and its daily adjustment. Highlighting that the association between the 
patient and the vision of the parents depends not only on the biological relationship, but on 
the frequency of daily contact and, therefore, in the immediate environment, supporting the 
role of environmental factors play in the perception of the disorder by the patient [133]. In 
this sense, as Kirkpatrick et al. point that [148] it is often forgotten the enormous complexity 
of schizophrenia and its impact, treatment and social and family functioning by focusing 
exclusively on psychotic symptoms.
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3. Conclusions
Deficits influence in cognitive domains in schizophrenia disorder is something that severely affect 
the clinic symptomatology as well as in social, labor and familiar adjustment of this patients, been 
something not to be ignored. Even so, so few familiar intervention programs are focus in explain 
and give intervention strategies to this deficits from home daily life. To these problems it might 
be added a big possibility of finding a lower cognitive deficit in some family members without 
pathology, with what it might be necessary to intervene face to them having a more realistic and 
adjusted perception of their children illness. With that we wish to avoid that cognitive disrepair 
might be seem as a personal product, an attitude lack or even a defiance sign [19].
Considering all the presented data about cognitive endophenotypes, it might be understand 
that a genetic component exits in the pathology, but we cannot erase environmental factors 
influence. It is not impossible to add changes in the psychosocial patient environment with 
whom it might improve, not only symptomatology, but it social and labor adjustment. In the 
other hand, it is already been commented that family might affect negatively in both patient 
types, frequently because a high expressed emotion [133] affecting patient self – perception 
and with it, its global functionality.
In this way, it was expected to find that, in general, familiar interactions to resolve problems 
might seem to be less constructive and more problematic when the family member suffers 
schizophrenia disorder versus others disorders. Salinger et al. [149] recently studied those 
interactions between parents and their teenage affected children (or at high risk) of psychosis 
and bipolar disorder. After control variables in the parents as: sex, age, functionality, educa-
tion. They observed that mothers of psychotic teenagers got a significantly more conflictive 
and less constructive communication than mothers of bipolar teenagers. The obvious conclu-
sion is that, given that the family environment among adolescents seeking help may be more 
challenging for families with adolescents with psychosis than in other serious pathologies. 
These families need a more intensive and focused communication training than would be 
required for families with adolescents with high-risk for bipolarity or other mood disorders.
In general, research highlights the importance of psychosocial and family factors. These 
interventions become more important if we take into account works such as Engh et al. [20] 
where he pointed out that an adequate awareness of deficits is related to a good adherence to 
treatment, but also to a bad perception of self-confidence and self-efficacy. And on the other 
hand, we cannot ignore that all these aspects will be terribly influenced by the more than 
frequent stigmatization suffered by these patients and the disastrous consequences of it in 
their personal perception [139–143]. As can be observed, the intervention of cognitive aspects, 
although important, must go beyond and in order to ensure their effectiveness, it should 
be encompassed in other fields closely linked to family interactions according to achieve a 
greater perception of the effectiveness of the subject, which can lead to greater functional 
participation as it would be through the promotion of self-esteem, absence of continuous 
criticism, skill training, daily contact and attitudes of acceptance and coping.
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